NCT04162795View on ClinicalTrials.gov

A Study to Evaluate Cooling Sensation of an Allergy Product in Adults With a History of Allergies

PHASE4CompletedINTERVENTIONAL

Enrollment

468

Participants

Timeline

Start Date

November 12, 2019

Primary Completion Date

November 13, 2019

Study Completion Date

November 13, 2019

Conditions

Allergic Rhinitis

Interventions

DRUG

Loratadine (Claritin, BAY76-2211)

Chewable tablet, oral, single dose

Trial Locations (1)

07666

Focus Pointe Global, Teaneck

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Bayer

INDUSTRY

NCT04162795 - A Study to Evaluate Cooling Sensation of an Allergy Product in Adults With a History of Allergies | Biotech Hunter | Biotech Hunter